Soleus Capital Management

Soleus Capital Management as of Sept. 30, 2022

Portfolio Holdings for Soleus Capital Management

Soleus Capital Management holds 76 positions in its portfolio as reported in the September 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
United Therapeutics Corporation (UTHR) 6.7 $49M 235k 209.38
Iveric Bio 6.1 $45M 2.5M 17.94
Edap Tms S A Sponsored Adr (EDAP) 5.5 $40M 4.9M 8.25
The Beauty Health Company Com Cl A (SKIN) 4.3 $31M 2.7M 11.79
Illumina (ILMN) 3.9 $29M 152k 190.79
CVS Caremark Corporation (CVS) 3.7 $27M 286k 95.37
Bioatla (BCAB) 3.6 $26M 3.4M 7.70
Eli Lilly & Co. (LLY) 3.6 $26M 81k 323.35
Charles River Laboratories (CRL) 3.5 $25M 129k 196.80
SurModics (SRDX) 3.2 $23M 769k 30.40
Arcellx Common Stock (ACLX) 3.2 $23M 1.2M 18.77
Organogenesis Hldgs (ORGO) 2.9 $21M 6.5M 3.24
Iradimed (IRMD) 2.8 $21M 685k 30.06
Tandem Diabetes Care Com New (TNDM) 2.7 $20M 415k 47.85
Theratechnologies 2.6 $19M 8.0M 2.37
Envista Hldgs Corp (NVST) 2.1 $16M 480k 32.81
Krystal Biotech (KRYS) 2.0 $15M 207k 69.70
C4 Therapeutics Com Stk (CCCC) 1.7 $13M 1.4M 8.77
Amylyx Pharmaceuticals (AMLX) 1.6 $12M 429k 28.15
Natera (NTRA) 1.6 $12M 276k 43.82
Inspire Med Sys (INSP) 1.6 $12M 67k 177.37
Cutera (CUTR) 1.6 $12M 256k 45.60
Dice Therapeutics 1.5 $11M 535k 20.28
CVRX (CVRX) 1.3 $9.9M 1.1M 9.33
Iovance Biotherapeutics (IOVA) 1.3 $9.8M 1.0M 9.58
Neuropace (NPCE) 1.2 $8.8M 2.3M 3.75
Vericel (VCEL) 1.2 $8.7M 374k 23.20
Vaxcyte (PCVX) 1.1 $8.1M 336k 24.00
Castle Biosciences (CSTL) 1.1 $7.8M 298k 26.08
Inari Medical Ord (NARI) 1.0 $7.4M 102k 72.64
Transmedics Group (TMDX) 1.0 $7.3M 175k 41.74
Humana (HUM) 0.9 $6.9M 14k 485.21
Nurix Therapeutics (NRIX) 0.9 $6.6M 504k 13.03
Inhibrx 0.9 $6.5M 364k 17.95
Intuitive Surgical Com New (ISRG) 0.9 $6.5M 35k 187.44
Enanta Pharmaceuticals (ENTA) 0.9 $6.4M 123k 51.87
Apollo Endosurgery 0.9 $6.3M 1.1M 5.51
Biogen Idec (BIIB) 0.8 $6.2M 23k 266.98
Keros Therapeutics (KROS) 0.7 $5.5M 146k 37.62
Alnylam Pharmaceuticals (ALNY) 0.7 $5.4M 27k 200.15
Adverum Biotechnologies 0.7 $5.3M 5.6M 0.95
Axogen (AXGN) 0.7 $5.1M 425k 11.92
Essa Pharma Com New (EPIX) 0.7 $4.8M 2.6M 1.82
Pieris Pharmaceuticals 0.6 $4.8M 4.1M 1.15
EXACT Sciences Corporation (EXAS) 0.6 $4.7M 145k 32.49
Colfax Corp (ENOV) 0.6 $4.7M 102k 46.07
Celcuity (CELC) 0.6 $4.5M 444k 10.04
Xenon Pharmaceuticals (XENE) 0.5 $3.5M 97k 36.09
Establishment Labs Holdings Ord (ESTA) 0.5 $3.4M 63k 54.62
Nevro (NVRO) 0.5 $3.4M 72k 46.60
Imago Biosciences 0.4 $3.2M 213k 15.05
Fibrogen (FGEN) 0.4 $3.0M 234k 13.01
Lyra Therapeutics (LYRA) 0.4 $3.0M 592k 5.01
Mirum Pharmaceuticals (MIRM) 0.4 $2.8M 136k 21.01
OraSure Technologies (OSUR) 0.3 $2.1M 565k 3.79
Inmode SHS (INMD) 0.3 $2.0M 67k 29.10
Dex (DXCM) 0.3 $1.9M 24k 80.55
89bio (ETNB) 0.3 $1.9M 330k 5.79
Eiger Biopharmaceuticals 0.2 $1.6M 219k 7.53
Anaptysbio Inc Common (ANAB) 0.2 $1.6M 64k 25.50
Chinook Therapeutics 0.2 $1.5M 78k 19.65
Fate Therapeutics (FATE) 0.2 $1.5M 67k 22.41
Crispr Therapeutics Namen Akt (CRSP) 0.2 $1.4M 22k 65.36
Novo-nordisk A S Adr (NVO) 0.2 $1.4M 14k 99.65
Verastem 0.2 $1.4M 1.6M 0.85
Xilio Therapeutics (XLO) 0.2 $1.3M 454k 2.91
Y Mabs Therapeutics (YMAB) 0.2 $1.3M 87k 14.42
Pepgen (PEPG) 0.2 $1.2M 130k 9.08
Bridgebio Pharma Note 2.500% 3/1 (Principal) 0.2 $1.2M 2.0M 0.59
Apellis Pharmaceuticals (APLS) 0.1 $915k 13k 68.28
Io Biotech (IOBT) 0.1 $781k 288k 2.71
Immunic (IMUX) 0.1 $758k 240k 3.16
Da32 Life Scnce Tec Acqstn C Class A Com 0.1 $487k 50k 9.74
Pliant Therapeutics (PLRX) 0.1 $443k 21k 20.90
Rocket Pharmaceuticals (RCKT) 0.1 $404k 25k 15.97
Miragen Therapeutics (VRDN) 0.1 $400k 20k 20.49